Free Trial
→ Altucher: Turn $900 into $108,000 in just 12 months? (From Paradigm Press) (Ad) Buy CSX Stock  Free CSX Stock Alerts

CSX (CSX) Financials

CSX logo
$28.27 +0.26 (+0.93%)
As of 04/14/2025 04:00 PM Eastern
Compare
Annual Income Statements for CSX

Annual Income Statements for CSX

This table shows CSX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 1,968 1,714 5,471 3,309 3,331 2,765 3,781 4,114 3,668 3,470
Consolidated Net Income / (Loss)		 1,968 1,714 5,471 3,309 3,331 2,765 3,781 4,114 3,668 3,470
Net Income / (Loss) Continuing Operations		 1,968 1,714 5,471 3,309 3,331 2,765 3,781 4,114 3,668 3,470
Total Pre-Tax Income 		3,138 2,741 3,142 4,304 4,316 3,627 4,951 5,345 4,829 4,555
Total Operating Income		 3,584 3,413 3,720 4,869 4,965 4,362 5,594 5,954 5,499 5,245
Total Gross Profit		 10,398 9,891 7,169 8,131 10,679 9,704 11,245 12,831 9,874 13,017
Total Revenue		 11,811 11,069 11,408 12,250 11,937 10,583 12,522 14,853 14,657 14,540
Operating Revenue		 11,811 11,069 11,408 12,250 11,937 10,583 12,522 14,853 14,657 14,540
Total Cost of Revenue		 1,413 1,178 4,239 4,119 1,258 879 1,277 2,022 4,783 1,523
Operating Cost of Revenue		 1,413 1,178 4,239 4,119 1,258 879 1,277 2,022 4,783 1,523
Total Operating Expenses		 6,814 6,478 3,449 3,262 5,714 5,342 5,651 6,877 4,375 7,772
Selling, General & Admin Expense		 5,646 5,227 2,113 1,931 4,516 3,994 4,685 5,613 2,802 6,017
Depreciation Expense		 1,208 1,301 1,315 1,331 1,349 1,383 1,420 1,502 1,607 1,658
Impairment Charge		 - - - - - - - 0.00 0.00 108
Other Special Charges / (Income)		 - - - - -151 -35 -454 -238 -34 -11
Total Other Income / (Expense), net		 -446 -672 -578 -565 -649 -735 -643 -609 -670 -690
Interest Expense		 544 694 546 - 737 754 722 742 809 832
Other Income / (Expense), net		 98 22 -32 -565 88 19 79 133 139 142
Income Tax Expense		 1,170 1,027 -2,329 995 985 862 1,170 1,231 1,161 1,085
Basic Earnings per Share		 $2.00 $1.81 $6.01 $3.86 $1.39 $1.20 $1.68 $1.93 $1.83 $1.79
Weighted Average Basic Shares Outstanding		 983M 947M 911M 857M 2.39B 2.30B 2.25B 2.14B 2.01B 1.94B
Diluted Earnings per Share		 $2.00 $1.81 $5.99 $3.84 $1.39 $1.20 $1.68 $1.92 $1.82 $1.79
Weighted Average Diluted Shares Outstanding		 984M 948M 914M 861M 2.40B 2.31B 2.26B 2.14B 2.01B 1.94B
Weighted Average Basic & Diluted Shares Outstanding		 984M 85.70B 910.30M 165.45B 773.83M 762.51M 2.19B 2.06B 1.96B 1.89B
Cash Dividends to Common per Share		 $0.70 $0.72 $0.78 $0.88 $0.96 $1.04 $0.37 $0.40 $0.44 $0.48

Quarterly Income Statements for CSX

This table shows CSX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders		 1,111 966 987 984 828 869 893 963 894 720
Consolidated Net Income / (Loss)		 1,111 966 987 984 828 869 893 963 894 720
Net Income / (Loss) Continuing Operations		 1,111 966 987 984 828 869 893 963 894 720
Total Pre-Tax Income 		1,423 1,235 1,304 1,296 1,102 1,127 1,185 1,267 1,184 919
Total Operating Income		 1,579 1,390 1,464 1,466 1,271 1,298 1,354 1,448 1,354 1,089
Total Gross Profit		 2,594 3,981 3,260 3,297 2,368 949 3,272 3,315 2,446 3,984
Total Revenue		 3,895 3,730 3,706 3,699 3,572 3,680 3,681 3,701 3,619 3,539
Operating Revenue		 3,895 3,730 3,706 3,699 3,572 3,680 3,681 3,701 3,619 3,539
Total Cost of Revenue		 1,301 -251 446 402 1,204 2,731 409 386 1,173 -445
Operating Cost of Revenue		 1,301 -251 446 402 1,204 2,731 409 386 1,173 -445
Total Operating Expenses		 1,015 2,591 1,796 1,831 1,097 -349 1,918 1,867 1,092 2,895
Selling, General & Admin Expense		 664 2,251 1,411 1,439 700 -748 1,509 1,465 675 2,368
Depreciation Expense		 378 395 393 404 403 407 410 410 416 422
Other Special Charges / (Income)		 -27 -55 -8.00 -12 -6.00 -8.00 -1.00 -8.00 1.00 -3.00
Total Other Income / (Expense), net		 -156 -155 -160 -170 -169 -171 -169 -181 -170 -170
Interest Expense		 193 199 201 201 203 204 210 209 206 207
Other Income / (Expense), net		 37 44 41 31 34 33 41 28 36 37
Income Tax Expense		 312 269 317 312 274 258 292 304 290 199
Basic Earnings per Share		 $0.52 $0.45 $0.48 $0.49 $0.42 $0.44 $0.46 $0.50 $0.46 $0.37
Weighted Average Basic Shares Outstanding		 2.12B 2.14B 2.05B 2.02B 1.99B 2.01B 1.96B 1.94B 1.94B 1.94B
Diluted Earnings per Share		 $0.52 $0.45 $0.48 $0.49 $0.41 $0.44 $0.46 $0.49 $0.46 $0.38
Weighted Average Diluted Shares Outstanding		 2.13B 2.14B 2.06B 2.03B 2.00B 2.01B 1.96B 1.95B 1.94B 1.94B
Weighted Average Basic & Diluted Shares Outstanding		 2.10B 2.06B 2.03B 2.01B 1.98B 1.96B 1.95B 1.94B 1.93B 1.89B

Annual Cash Flow Statements for CSX

This table details how cash moves in and out of CSX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 -41 -25 -202 457 100 2,171 -890 -306 -580 -420
Net Cash From Operating Activities		 3,370 3,041 3,472 4,641 4,850 4,263 5,099 5,526 5,514 5,247
Net Cash From Continuing Operating Activities		 3,370 3,041 3,472 4,641 4,850 4,263 5,099 5,526 5,514 5,247
Net Income / (Loss) Continuing Operations		 1,968 1,714 5,471 3,309 3,331 2,765 3,781 4,114 3,668 3,470
Consolidated Net Income / (Loss)		 1,968 1,714 5,471 3,309 3,331 2,765 3,781 4,114 3,668 3,470
Depreciation Expense		 1,208 1,301 1,315 1,331 1,349 1,383 1,420 1,502 1,607 1,658
Non-Cash Adjustments To Reconcile Net Income		 -130 -178 88 -154 -151 -35 -454 -238 -34 97
Changes in Operating Assets and Liabilities, net		 324 204 -3,402 155 321 150 352 148 273 22
Net Cash From Investing Activities		 -2,892 -1,798 -1,495 -1,684 -2,102 -649 -1,877 -2,063 -2,227 -2,605
Net Cash From Continuing Investing Activities		 -2,892 -1,798 -1,495 -1,684 -2,102 -649 -1,877 -2,063 -2,227 -2,605
Purchase of Property, Plant & Equipment		 -2,562 -2,398 -2,040 -1,745 -1,657 -1,626 -1,791 -2,113 -2,257 -2,529
Acquisitions		 - - - - - 0.00 -541 -227 -31 -70
Purchase of Investments		 -1,739 -929 -782 -736 -2,838 -426 -75 -59 -104 -66
Sale of Property, Plant & Equipment		 147 195 97 319 254 56 529 294 88 66
Sale and/or Maturity of Investments		 1,225 1,325 1,193 505 2,108 1,424 5.00 9.00 153 91
Other Investing Activities, net		 37 9.00 37 -27 31 -77 -4.00 33 -76 -97
Net Cash From Financing Activities		 -519 -1,268 -2,179 -2,500 -2,648 -1,443 -4,112 -3,769 -3,867 -3,062
Net Cash From Continuing Financing Activities		 -519 -1,268 -2,179 -2,500 -2,648 -1,443 -4,112 -3,769 -3,867 -3,062
Repayment of Debt		 -229 -1,732 -351 -78 -518 -779 -387 -186 -103 -445
Repurchase of Common Equity		 -804 -1,056 -1,970 -4,671 -3,373 -867 -2,886 -4,731 -3,482 -2,237
Payment of Dividends		 -686 -680 -708 -751 -763 -797 -839 -852 -882 -930
Issuance of Debt		 1,200 2,200 850 3,000 2,000 1,000 0.00 2,000 600 550
Cash Interest Paid		 566 606 555 614 717 750 718 729 806 850
Cash Income Taxes Paid		 768 580 911 814 691 664 931 1,167 630 1,076

Quarterly Cash Flow Statements for CSX

This table details how cash moves in and out of CSX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents		 1,587 -378 -667 -310 404 -7.00 130 -245 406 -711
Net Cash From Operating Activities		 1,725 1,271 1,251 1,222 1,552 1,489 1,084 1,089 1,686 1,388
Net Cash From Continuing Operating Activities		 1,725 1,271 1,251 1,222 1,552 1,489 1,084 1,089 1,686 1,388
Net Income / (Loss) Continuing Operations		 1,111 966 987 971 828 882 893 950 894 733
Consolidated Net Income / (Loss)		 1,111 966 987 971 828 882 893 950 894 733
Depreciation Expense		 378 395 393 406 403 405 410 410 416 422
Non-Cash Adjustments To Reconcile Net Income		 -27 -55 -8.00 -12 -6.00 -8.00 -1.00 -8.00 1.00 105
Changes in Operating Assets and Liabilities, net		 263 -35 -121 -143 327 210 -218 -263 375 128
Net Cash From Investing Activities		 -625 -419 -480 -465 -561 -721 -504 -544 -674 -883
Net Cash From Continuing Investing Activities		 -625 -419 -480 -465 -561 -721 -504 -544 -674 -883
Purchase of Property, Plant & Equipment		 -626 -676 -443 -554 -574 -686 -524 -542 -625 -838
Acquisitions		 -15 -4.00 -2.00 -29 - - -26 -24 -18 -2.00
Purchase of Investments		 - -40 -101 -1.00 -1.00 -1.00 0.00 - - -66
Sale of Property, Plant & Equipment		 22 243 8.00 44 13 23 0.00 43 7.00 16
Sale and/or Maturity of Investments		 - - 53 100 - - 81 - - 10
Other Investing Activities, net		 -6.00 58 5.00 -25 1.00 -57 -35 -21 -38 -3.00
Net Cash From Financing Activities		 487 -1,230 -1,438 -1,067 -587 -775 -450 -790 -606 -1,216
Net Cash From Continuing Financing Activities		 487 -1,230 -1,438 -1,067 -587 -775 -450 -790 -606 -1,216
Repayment of Debt		 -106 -2.00 -145 18 2.00 22 32 6.00 -522 39
Repurchase of Common Equity		 -1,195 -1,021 -1,067 -863 -971 -581 -247 -563 -402 -1,025
Payment of Dividends		 -212 -207 -226 -222 -218 -216 -235 -233 -232 -230

Annual Balance Sheets for CSX

This table presents CSX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets		 34,745 35,414 35,739 36,729 38,257 39,793 40,531 37,102 42,212 42,764
Total Current Assets		 2,840 2,487 1,915 2,565 3,278 4,441 3,873 2,024 3,359 2,820
Cash & Equivalents		 628 603 401 858 958 3,129 2,239 1,933 1,353 933
Short-Term Investments		 810 417 18 253 996 2.00 77 0.00 83 72
Accounts Receivable		 982 938 970 1,010 986 912 1,148 0.00 1,393 1,326
Inventories, net		 350 407 372 263 261 302 339 0.00 440 414
Other Current Assets		 70 122 154 181 77 96 70 91 90 75
Plant, Property, & Equipment, net		 30,174 31,150 31,764 31,998 32,168 32,444 33,015 34,070 34,721 35,658
Plant, Property & Equipment, gross		 41,574 43,227 44,324 44,805 45,100 45,530 46,505 48,463 50,281 52,191
Accumulated Depreciation		 11,400 12,077 12,560 12,807 12,932 13,086 13,490 14,393 15,560 16,533
Total Noncurrent Assets		 1,731 1,777 2,060 2,166 2,811 2,908 3,643 1,008 4,132 4,286
Long-Term Investments		 1,394 1,459 1,686 1,779 1,879 1,985 2,099 0.00 2,397 2,520
Goodwill		 - - - - - 63 451 502 506 433
Other Noncurrent Operating Assets		 337 318 374 387 932 860 1,093 506 1,229 1,333
Total Liabilities & Shareholders' Equity		 34,745 35,414 35,739 36,729 38,257 39,793 40,531 18,249 42,212 42,764
Total Liabilities		 23,077 23,720 21,018 24,149 26,394 26,683 27,031 8,430 30,227 30,257
Total Current Liabilities		 1,952 2,040 1,894 1,915 2,151 2,019 2,233 2,446 3,223 3,276
Short-Term Debt		 20 331 19 18 245 401 181 0.00 558 606
Accounts Payable		 764 806 847 949 1,043 809 963 0.00 1,237 1,290
Accrued Expenses		 131 115 108 113 100 90 118 0.00 144 149
Current Deferred & Payable Income Tax Liabilities		 108 129 157 106 69 73 134 0.00 524 508
Current Employee Benefit Liabilities		 490 545 602 550 489 482 630 682 517 480
Other Current Liabilities		 439 114 161 179 205 164 207 228 243 243
Total Noncurrent Liabilities		 21,125 21,680 19,124 22,234 24,243 24,664 24,798 7,520 27,004 26,981
Long-Term Debt		 10,515 10,962 11,790 14,739 15,993 16,304 16,185 0.00 17,975 17,897
Noncurrent Deferred & Payable Income Tax Liabilities		 9,179 9,596 6,418 6,690 6,961 7,168 7,383 7,520 7,699 7,725
Other Noncurrent Operating Liabilities		 1,431 1,122 916 805 1,289 1,192 1,230 0.00 1,330 1,359
Total Equity & Noncontrolling Interests		 11,668 11,694 14,721 12,580 11,863 13,110 13,500 12,469 11,985 12,507
Total Preferred & Common Equity		 11,652 11,679 14,705 12,563 11,848 13,101 13,490 9,819 11,980 12,502
Total Common Equity		 11,652 11,679 14,705 12,563 11,848 13,101 13,490 9,819 11,980 12,502
Common Stock		 1,079 1,066 1,107 1,067 1,119 2,440 2,268 0.00 2,650 2,746
Retained Earnings		 11,238 11,253 14,084 12,157 11,404 11,259 11,630 10,229 9,609 9,988
Accumulated Other Comprehensive Income / (Loss)		 -665 -640 -486 -661 -675 -598 -408 -410 -279 -232
Noncontrolling Interest		 16 15 16 17 15 9.00 10 0.00 5.00 5.00

Quarterly Balance Sheets for CSX

This table presents CSX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Total Assets		 42,242 37,102 41,478 35,803 36,742 42,212 42,695 42,362 43,069 42,764
Total Current Assets		 4,310 2,024 3,355 1,063 1,862 3,359 3,472 3,180 3,577 2,820
Cash & Equivalents		 2,311 1,933 1,291 956 1,360 1,353 1,483 1,238 1,644 933
Short-Term Investments		 88 0.00 178 0.00 0.00 83 2.00 4.00 12 72
Accounts Receivable		 1,467 0.00 1,377 0.00 0.00 1,393 1,400 1,430 1,413 1,326
Inventories, net		 365 0.00 394 0.00 427 440 451 417 415 414
Other Current Assets		 79 91 115 107 75 90 136 91 93 75
Plant, Property, & Equipment, net		 33,956 34,070 34,293 34,267 34,441 34,721 35,056 34,949 35,170 35,658
Plant, Property & Equipment, gross		 47,734 48,463 48,441 49,241 49,691 50,281 50,661 51,065 51,503 52,191
Accumulated Depreciation		 13,778 14,393 14,148 14,974 15,250 15,560 15,605 16,116 16,333 16,533
Total Noncurrent Assets		 3,976 1,008 3,830 473 439 4,132 4,167 4,233 4,322 4,286
Long-Term Investments		 2,289 0.00 2,313 0.00 0.00 2,397 2,424 2,455 2,485 2,520
Goodwill		 537 502 500 0.00 0.00 506 520 535 544 433
Other Noncurrent Operating Assets		 1,150 506 1,017 473 439 1,229 1,223 1,243 1,293 1,333
Total Liabilities & Shareholders' Equity		 42,242 18,249 41,478 17,715 17,117 42,212 42,695 42,362 43,069 42,764
Total Liabilities		 29,359 8,430 29,144 8,275 7,998 30,227 30,093 29,742 30,133 30,257
Total Current Liabilities		 2,508 2,446 2,321 2,074 2,934 3,223 3,024 2,739 2,569 3,276
Short-Term Debt		 155 0.00 11 0.00 0.00 558 557 557 6.00 606
Accounts Payable		 1,152 0.00 1,203 0.00 0.00 1,237 1,306 1,192 1,301 1,290
Accrued Expenses		 113 0.00 151 0.00 0.00 144 140 148 147 149
Current Deferred & Payable Income Tax Liabilities		 156 0.00 361 0.00 361 524 382 122 379 508
Current Employee Benefit Liabilities		 727 682 367 444 0.00 517 387 469 470 480
Other Current Liabilities		 205 228 228 226 0.00 243 252 251 266 243
Total Noncurrent Liabilities		 26,851 7,520 26,823 7,605 7,637 27,004 27,069 27,003 27,564 26,981
Long-Term Debt		 17,895 0.00 17,911 0.00 0.00 17,975 17,944 17,951 18,535 17,897
Noncurrent Deferred & Payable Income Tax Liabilities		 7,632 7,520 7,605 7,605 7,637 7,699 7,759 7,716 7,721 7,725
Other Noncurrent Operating Liabilities		 1,324 0.00 1,307 0.00 0.00 1,330 1,366 1,336 1,308 1,359
Total Equity & Noncontrolling Interests		 12,883 12,469 12,334 12,074 11,756 11,985 12,602 12,620 12,936 12,507
Total Preferred & Common Equity		 12,874 9,819 12,326 9,440 9,119 11,980 12,597 12,616 12,931 12,502
Total Common Equity		 12,874 9,819 12,326 9,440 9,119 11,980 12,597 12,616 12,931 12,502
Common Stock		 2,657 0.00 2,620 0.00 0.00 2,650 2,698 2,697 2,743 2,746
Retained Earnings		 10,537 10,229 10,092 9,852 9,513 9,609 10,205 10,189 10,457 9,988
Accumulated Other Comprehensive Income / (Loss)		 -320 -410 -386 -412 -394 -279 -306 -270 -269 -232
Noncontrolling Interest		 9.00 0.00 8.00 0.00 0.00 5.00 5.00 4.00 5.00 5.00

Annual Metrics and Ratios for CSX

This table displays calculated financial ratios and metrics derived from CSX's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 -6.77% -6.28% 3.06% 7.38% -2.56% -11.34% 18.32% 18.62% -1.32% -0.80%
EBITDA Growth		 2.82% -3.15% 5.64% 12.63% 13.61% -9.97% 23.06% 6.99% -4.53% -2.76%
EBIT Growth		 2.14% -6.71% 7.37% 16.70% 17.40% -13.30% 29.49% 7.30% -7.38% -4.45%
NOPAT Growth		 -1.73% -5.05% 203.50% -42.21% 2.36% -13.22% 28.47% 7.27% -8.86% -4.34%
Net Income Growth		 2.13% -12.91% 219.19% -39.52% 0.66% -16.99% 36.75% 8.81% -10.84% -5.40%
EPS Growth		 4.17% -9.50% 230.94% -35.89% 0.66% -16.99% 40.00% 14.29% -5.21% -1.65%
Operating Cash Flow Growth		 0.81% -9.76% 14.17% 33.67% 4.50% -12.10% 19.61% 8.37% -0.22% -4.84%
Free Cash Flow Firm Growth		 8.00% -32.52% 156.76% 45.34% 7.78% -27.84% 21.62% -6.40% 28.41% -24.47%
Invested Capital Growth		 4.14% 5.87% 19.10% 0.09% -0.73% 1.78% 3.04% 5.06% -0.20% 3.00%
Revenue Q/Q Growth		 -3.36% 2.37% -1.50% 2.34% -2.12% -0.56% 5.05% 2.08% -0.34% -0.96%
EBITDA Q/Q Growth		 -0.43% 3.88% 1.83% -7.92% 9.19% 0.28% 3.13% 1.12% -2.16% -3.48%
EBIT Q/Q Growth		 -1.15% 4.28% 2.82% -10.28% 11.97% 0.30% 3.69% 0.81% -2.96% -4.72%
NOPAT Q/Q Growth		 -3.16% 6.57% 190.90% -49.98% -1.35% 0.65% 3.14% 0.62% -3.22% -4.66%
Net Income Q/Q Growth		 -1.25% -0.46% 205.81% -49.91% -2.12% -0.40% 4.82% 0.78% -3.90% -5.35%
EPS Q/Q Growth		 -0.50% 1.12% 208.76% -50.58% -2.12% -0.40% 4.35% 0.00% -4.71% -4.79%
Operating Cash Flow Q/Q Growth		 -5.15% -9.12% 1.70% 15.53% -2.45% 0.52% 2.93% -0.16% 2.32% -2.53%
Free Cash Flow Firm Q/Q Growth		 17.56% -30.05% 48.11% 5.77% -3.13% -7.87% 10.49% -9.39% 33.19% -24.61%
Invested Capital Q/Q Growth		 -0.27% 2.53% 19.15% -0.07% 0.24% 1.35% 0.49% 1.88% -2.55% 0.55%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 88.04% 89.36% 62.84% 66.38% 89.46% 91.69% 89.80% 86.39% 67.37% 89.53%
EBITDA Margin		 41.40% 42.79% 43.86% 46.00% 53.63% 54.46% 56.64% 51.09% 49.43% 48.45%
Operating Margin		 30.34% 30.83% 32.61% 39.75% 41.59% 41.22% 44.67% 40.09% 37.52% 36.07%
EBIT Margin		 31.17% 31.03% 32.33% 35.13% 42.33% 41.40% 45.30% 40.98% 38.47% 37.05%
Profit (Net Income) Margin		 16.66% 15.48% 47.96% 27.01% 27.90% 26.13% 30.19% 27.70% 25.03% 23.87%
Tax Burden Percent		 62.72% 62.53% 174.12% 76.88% 77.18% 76.23% 76.37% 76.97% 75.96% 76.18%
Interest Burden Percent		 85.23% 79.80% 85.20% 100.00% 85.41% 82.79% 87.27% 87.81% 85.65% 84.56%
Effective Tax Rate		 37.28% 37.47% -74.12% 23.12% 22.82% 23.77% 23.63% 23.03% 24.04% 23.82%
Return on Invested Capital (ROIC)		 11.84% 10.70% 28.83% 15.32% 15.73% 13.58% 17.04% 17.56% 15.64% 14.75%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.14% 5.62% 17.96% 11.29% 11.60% 8.91% 12.87% 13.99% 12.12% 11.21%
Return on Net Nonoperating Assets (RNNOA)		 5.39% 3.97% 12.59% 8.92% 11.52% 8.56% 11.38% 14.12% 14.36% 13.58%
Return on Equity (ROE)		 17.23% 14.67% 41.42% 24.24% 27.26% 22.14% 28.42% 31.68% 30.00% 28.34%
Cash Return on Invested Capital (CROIC)		 7.78% 5.00% 11.40% 15.23% 16.47% 11.82% 14.04% 12.63% 15.84% 11.80%
Operating Return on Assets (OROA)		 10.86% 9.79% 10.37% 11.88% 13.48% 11.23% 14.13% 15.68% 14.22% 12.68%
Return on Assets (ROA)		 5.81% 4.89% 15.38% 9.13% 8.88% 7.09% 9.41% 10.60% 9.25% 8.17%
Return on Common Equity (ROCE)		 17.20% 14.65% 41.37% 24.21% 27.22% 22.12% 28.40% 28.44% 26.74% 28.32%
Return on Equity Simple (ROE_SIMPLE)		 16.89% 14.68% 37.21% 26.34% 28.11% 21.11% 28.03% 41.90% 30.62% 27.76%
Net Operating Profit after Tax (NOPAT)		 2,248 2,134 6,477 3,743 3,832 3,325 4,272 4,583 4,177 3,996
NOPAT Margin		 19.03% 19.28% 56.78% 30.56% 32.10% 31.42% 34.12% 30.85% 28.50% 27.48%
Net Nonoperating Expense Percent (NNEP)		 3.70% 5.09% 10.87% 4.03% 4.13% 4.67% 4.17% 3.58% 3.51% 3.54%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 36.75% 13.69% 12.89%
Cost of Revenue to Revenue		 11.96% 10.64% 37.16% 33.62% 10.54% 8.31% 10.20% 13.61% 32.63% 10.47%
SG&A Expenses to Revenue		 47.80% 47.22% 18.52% 15.76% 37.83% 37.74% 37.41% 37.79% 19.12% 41.38%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 57.69% 58.52% 30.23% 26.63% 47.87% 50.48% 45.13% 46.30% 29.85% 53.45%
Earnings before Interest and Taxes (EBIT)		 3,682 3,435 3,688 4,304 5,053 4,381 5,673 6,087 5,638 5,387
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 4,890 4,736 5,003 5,635 6,402 5,764 7,093 7,589 7,245 7,045
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 1.93 2.61 3.07 3.89 4.51 5.07 5.98 6.45 5.64 4.98
Price to Tangible Book Value (P/TBV)		 1.93 2.61 3.07 3.89 4.51 5.09 6.19 6.80 5.89 5.16
Price to Revenue (P/Rev)		 1.90 2.75 3.96 3.99 4.48 6.27 6.44 4.27 4.61 4.28
Price to Earnings (P/E)		 11.41 17.76 8.26 14.76 16.04 24.01 21.33 15.40 18.43 17.93
Dividend Yield		 3.04% 2.22% 1.54% 1.52% 1.41% 1.20% 1.03% 1.33% 1.29% 1.49%
Earnings Yield		 8.76% 5.63% 12.11% 6.77% 6.23% 4.17% 4.69% 6.49% 5.43% 5.58%
Enterprise Value to Invested Capital (EV/IC)		 1.56 1.92 2.25 2.48 2.71 3.16 3.64 2.30 3.08 2.81
Enterprise Value to Revenue (EV/Rev)		 2.56 3.55 4.81 4.96 5.52 7.37 7.40 4.13 5.61 5.31
Enterprise Value to EBITDA (EV/EBITDA)		 6.17 8.29 10.97 10.78 10.29 13.53 13.06 8.09 11.36 10.96
Enterprise Value to EBIT (EV/EBIT)		 8.20 11.43 14.88 14.11 13.03 17.80 16.33 10.09 14.60 14.33
Enterprise Value to NOPAT (EV/NOPAT)		 13.43 18.40 8.47 16.22 17.19 23.45 21.68 13.40 19.70 19.32
Enterprise Value to Operating Cash Flow (EV/OCF)		 8.95 12.92 15.81 13.09 13.58 18.29 18.17 11.11 14.92 14.72
Enterprise Value to Free Cash Flow (EV/FCFF)		 20.42 39.39 21.44 16.32 16.42 26.94 26.31 18.64 19.45 24.16
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.90 0.97 0.80 1.17 1.37 1.27 1.21 0.00 1.55 1.48
Long-Term Debt to Equity		 0.90 0.94 0.80 1.17 1.35 1.24 1.20 0.00 1.50 1.43
Financial Leverage		 0.66 0.71 0.70 0.79 0.99 0.96 0.88 1.01 1.18 1.21
Leverage Ratio		 2.97 3.00 2.69 2.65 3.07 3.13 3.02 2.99 3.24 3.47
Compound Leverage Factor		 2.53 2.40 2.29 2.65 2.62 2.59 2.63 2.63 2.78 2.93
Debt to Total Capital		 47.45% 49.13% 44.51% 53.98% 57.78% 56.03% 54.80% 0.00% 60.73% 59.67%
Short-Term Debt to Total Capital		 0.09% 1.44% 0.07% 0.07% 0.87% 1.35% 0.61% 0.00% 1.83% 1.95%
Long-Term Debt to Total Capital		 47.36% 47.69% 44.44% 53.92% 56.91% 54.68% 54.19% 0.00% 58.90% 57.71%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.07% 0.07% 0.06% 0.06% 0.05% 0.03% 0.03% 0.00% 0.02% 0.02%
Common Equity to Total Capital		 52.48% 50.81% 55.43% 45.96% 42.16% 43.94% 45.17% 78.75% 39.26% 40.32%
Debt to EBITDA		 2.15 2.38 2.36 2.62 2.54 2.90 2.31 0.00 2.56 2.63
Net Debt to EBITDA		 1.58 1.86 1.94 2.11 1.94 2.01 1.68 0.00 2.03 2.13
Long-Term Debt to EBITDA		 2.15 2.31 2.36 2.62 2.50 2.83 2.28 0.00 2.48 2.54
Debt to NOPAT		 4.69 5.29 1.82 3.94 4.24 5.02 3.83 0.00 4.44 4.63
Net Debt to NOPAT		 3.43 4.13 1.50 3.17 3.24 3.49 2.80 0.00 3.52 3.75
Long-Term Debt to NOPAT		 4.68 5.14 1.82 3.94 4.17 4.90 3.79 0.00 4.30 4.48
Altman Z-Score		 1.76 1.86 2.50 2.42 2.42 2.59 3.01 5.82 2.45 2.30
Noncontrolling Interest Sharing Ratio		 0.18% 0.13% 0.12% 0.12% 0.13% 0.10% 0.07% 10.24% 10.86% 0.04%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 1.45 1.22 1.01 1.34 1.52 2.20 1.73 0.83 1.04 0.86
Quick Ratio		 1.24 0.96 0.73 1.11 1.37 2.00 1.55 0.79 0.88 0.71
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1,478 997 2,560 3,721 4,011 2,894 3,520 3,295 4,231 3,196
Operating Cash Flow to CapEx		 139.54% 138.04% 178.69% 325.46% 345.69% 271.53% 404.04% 303.79% 254.22% 213.03%
Free Cash Flow to Firm to Interest Expense		 2.72 1.44 4.69 0.00 5.44 3.84 4.88 4.44 5.23 3.84
Operating Cash Flow to Interest Expense		 6.19 4.38 6.36 0.00 6.58 5.65 7.06 7.45 6.82 6.31
Operating Cash Flow Less CapEx to Interest Expense		 1.76 1.21 2.80 0.00 4.68 3.57 5.31 5.00 4.13 3.35
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.35 0.32 0.32 0.34 0.32 0.27 0.31 0.38 0.37 0.34
Accounts Receivable Turnover		 11.19 11.53 11.96 12.37 11.96 11.15 12.16 0.00 0.00 10.70
Inventory Turnover		 4.54 3.11 10.88 12.97 4.80 3.12 3.98 0.00 0.00 3.57
Fixed Asset Turnover		 0.40 0.36 0.36 0.38 0.37 0.33 0.38 0.44 0.43 0.41
Accounts Payable Turnover		 1.76 1.50 5.13 4.59 1.26 0.95 1.44 0.00 0.00 1.21
Days Sales Outstanding (DSO)		 32.62 31.66 30.52 29.50 30.52 32.73 30.02 0.00 0.00 34.13
Days Inventory Outstanding (DIO)		 80.47 117.28 33.54 28.13 76.02 116.89 91.61 0.00 0.00 102.33
Days Payable Outstanding (DPO)		 207.81 243.23 71.17 79.58 288.98 384.52 253.24 0.00 0.00 302.81
Cash Conversion Cycle (CCC)		 -94.73 -94.30 -7.10 -21.94 -182.45 -234.89 -131.61 0.00 0.00 -166.35
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 19,371 20,508 24,425 24,447 24,268 24,699 25,451 26,739 26,685 27,485
Invested Capital Turnover		 0.62 0.56 0.51 0.50 0.49 0.43 0.50 0.57 0.55 0.54
Increase / (Decrease) in Invested Capital		 770 1,137 3,917 22 -179 431 752 1,288 -54 800
Enterprise Value (EV)		 30,177 39,276 54,888 60,735 65,851 77,977 92,623 61,415 82,292 77,213
Market Capitalization		 22,458 30,447 45,168 48,851 53,431 66,379 80,662 63,348 67,587 62,230
Book Value per Share		 $11.95 $12.47 $16.45 $14.88 $15.14 $17.13 $6.08 $4.67 $6.06 $6.48
Tangible Book Value per Share		 $11.95 $12.47 $16.45 $14.88 $15.14 $17.05 $5.88 $4.43 $5.81 $6.26
Total Capital		 22,203 22,987 26,530 27,337 28,101 29,815 29,866 12,469 30,518 31,010
Total Debt		 10,535 11,293 11,809 14,757 16,238 16,705 16,366 0.00 18,533 18,503
Total Long-Term Debt		 10,515 10,962 11,790 14,739 15,993 16,304 16,185 0.00 17,975 17,897
Net Debt		 7,703 8,814 9,704 11,867 12,405 11,589 11,951 -1,933 14,700 14,978
Capital Expenditures (CapEx)		 2,415 2,203 1,943 1,426 1,403 1,570 1,262 1,819 2,169 2,463
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -530 -242 -379 -443 -582 -308 -495 -2,355 -742 -855
Debt-free Net Working Capital (DFNWC)		 908 778 40 668 1,372 2,823 1,821 -422 694 150
Net Working Capital (NWC)		 888 447 21 650 1,127 2,422 1,640 -422 136 -456
Net Nonoperating Expense (NNE)		 280 420 1,006 434 501 560 491 469 509 526
Net Nonoperating Obligations (NNO)		 7,703 8,814 9,704 11,867 12,405 11,589 11,951 14,270 14,700 14,978
Total Depreciation and Amortization (D&A)		 1,208 1,301 1,315 1,331 1,349 1,383 1,420 1,502 1,607 1,658
Debt-free, Cash-free Net Working Capital to Revenue		 -4.49% -2.19% -3.32% -3.62% -4.88% -2.91% -3.95% -15.86% -5.06% -5.88%
Debt-free Net Working Capital to Revenue		 7.69% 7.03% 0.35% 5.45% 11.49% 26.67% 14.54% -2.84% 4.73% 1.03%
Net Working Capital to Revenue		 7.52% 4.04% 0.18% 5.31% 9.44% 22.89% 13.10% -2.84% 0.93% -3.14%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.67 $0.60 $2.00 $1.29 $1.39 $1.20 $1.68 $1.95 $1.85 $1.79
Adjusted Weighted Average Basic Shares Outstanding		 2.95B 2.84B 2.73B 2.57B 2.39B 2.30B 2.25B 2.14B 2.01B 1.94B
Adjusted Diluted Earnings per Share		 $0.67 $0.60 $2.00 $1.28 $1.39 $1.20 $1.68 $1.95 $1.85 $1.79
Adjusted Weighted Average Diluted Shares Outstanding		 2.95B 2.84B 2.74B 2.58B 2.39B 2.30B 2.26B 2.14B 2.01B 1.94B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 2.89B 2.78B 2.66B 2.45B 2.32B 2.29B 2.19B 2.06B 1.96B 1.89B
Normalized Net Operating Profit after Tax (NOPAT)		 2,248 2,134 2,772 3,743 3,715 3,299 3,925 4,400 4,151 4,070
Normalized NOPAT Margin		 19.03% 19.28% 24.30% 30.56% 31.12% 31.17% 31.35% 29.62% 28.32% 27.99%
Pre Tax Income Margin		 26.57% 24.76% 27.54% 35.13% 36.16% 34.27% 39.54% 35.99% 32.95% 31.33%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 6.77 4.95 6.75 0.00 6.86 5.81 7.86 8.20 6.97 6.47
NOPAT to Interest Expense		 4.13 3.08 11.86 0.00 5.20 4.41 5.92 6.18 5.16 4.80
EBIT Less CapEx to Interest Expense		 2.33 1.78 3.20 0.00 4.95 3.73 6.11 5.75 4.29 3.51
NOPAT Less CapEx to Interest Expense		 -0.31 -0.10 8.30 0.00 3.30 2.33 4.17 3.72 2.48 1.84
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 34.86% 39.67% 12.94% 22.70% 22.91% 28.82% 22.19% 20.71% 24.05% 26.80%
Augmented Payout Ratio		 75.71% 101.28% 48.95% 163.86% 124.17% 60.18% 98.52% 135.71% 118.97% 91.27%

Quarterly Metrics and Ratios for CSX

This table displays calculated financial ratios and metrics derived from CSX's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 18.32% 8.84% 8.58% -3.04% -8.29% -1.34% -0.67% 0.05% 1.32% -3.83%
EBITDA Growth		 9.38% 4.81% 13.79% -9.29% -14.34% -5.08% -4.90% -0.89% 5.74% -10.83%
EBIT Growth		 10.99% 3.54% 15.06% -13.42% -19.25% -7.18% -7.31% -1.40% 6.51% -15.40%
NOPAT Growth		 13.43% 2.69% 13.60% -13.56% -22.54% -7.95% -7.92% -1.12% 7.06% -14.75%
Net Income Growth		 14.77% 3.43% 14.90% -16.47% -25.47% -10.04% -9.52% -2.13% 7.97% -17.15%
EPS Growth		 20.93% 7.14% 23.08% -9.26% -21.15% -2.22% -4.17% 0.00% 12.20% -13.64%
Operating Cash Flow Growth		 21.48% -0.70% -3.70% -0.73% -10.03% 17.15% -13.35% -10.88% 8.63% -6.78%
Free Cash Flow Firm Growth		 140.63% -165.44% -106.09% 448.86% -158.46% 625.43% 3,135.22% -70.83% 681.66% -94.96%
Invested Capital Growth		 3.62% 5.06% 4.41% 1.08% 4.34% -0.20% 2.72% 3.23% -0.18% 3.00%
Revenue Q/Q Growth		 2.10% -4.24% -0.64% -0.19% -3.43% 3.02% 0.03% 0.54% -2.22% -2.21%
EBITDA Q/Q Growth		 -4.96% -8.27% 0.11% 0.26% -10.25% 1.64% 1.06% 4.49% -4.24% -14.29%
EBIT Q/Q Growth		 -6.54% -11.26% 0.13% -0.53% -12.83% 1.99% 1.90% 5.81% -5.83% -18.99%
NOPAT Q/Q Growth		 -4.26% -11.81% -2.71% 0.45% -14.20% 4.80% -0.92% 7.86% -7.11% -16.55%
Net Income Q/Q Growth		 -5.69% -13.05% -3.05% -0.30% -15.85% 4.95% -0.56% 7.84% -7.17% -19.46%
EPS Q/Q Growth		 -3.70% -13.46% 0.00% 2.08% -16.33% 7.32% 0.00% 6.52% -6.12% -17.39%
Operating Cash Flow Q/Q Growth		 40.13% -26.32% -8.28% -2.32% 27.00% -4.06% -27.73% 0.46% 54.82% -17.68%
Free Cash Flow Firm Q/Q Growth		 232.62% -163.78% -102.80% 8,468.01% -122.22% 673.23% -48.38% -19.57% 343.08% -95.03%
Invested Capital Q/Q Growth		 -0.16% 1.88% 0.90% 0.37% 3.06% -2.55% 1.91% 0.87% -0.35% 0.55%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 66.60% 106.73% 87.97% 89.13% 66.29% 25.79% 88.89% 89.57% 67.59% 112.57%
EBITDA Margin		 51.19% 49.03% 51.21% 51.45% 47.82% 47.17% 49.04% 50.96% 49.90% 43.74%
Operating Margin		 40.54% 37.27% 39.50% 39.63% 35.58% 35.27% 36.78% 39.12% 37.41% 30.77%
EBIT Margin		 41.49% 38.45% 40.61% 40.47% 36.53% 36.17% 37.90% 39.88% 38.41% 31.82%
Profit (Net Income) Margin		 28.52% 25.90% 26.63% 26.60% 23.18% 23.61% 24.26% 26.02% 24.70% 20.34%
Tax Burden Percent		 78.07% 78.22% 75.69% 75.93% 75.14% 77.11% 75.36% 76.01% 75.51% 78.35%
Interest Burden Percent		 88.06% 86.12% 86.64% 86.57% 84.44% 84.67% 84.95% 85.84% 85.18% 81.62%
Effective Tax Rate		 21.93% 21.78% 24.31% 24.07% 24.86% 22.89% 24.64% 23.99% 24.49% 21.65%
Return on Invested Capital (ROIC)		 17.86% 16.59% 17.48% 17.11% 14.66% 14.92% 15.11% 16.12% 15.16% 12.94%
ROIC Less NNEP Spread (ROIC-NNEP)		 16.90% 15.67% 16.55% 16.18% 13.79% 14.01% 14.23% 15.18% 14.30% 12.04%
Return on Net Nonoperating Assets (RNNOA)		 16.56% 15.82% 17.05% 17.74% 16.22% 16.60% 16.39% 18.01% 17.39% 14.59%
Return on Equity (ROE)		 34.41% 32.41% 34.53% 34.85% 30.89% 31.52% 31.51% 34.13% 32.55% 27.54%
Cash Return on Invested Capital (CROIC)		 14.10% 12.63% 14.08% 16.30% 11.85% 15.84% 12.73% 12.09% 15.49% 11.80%
Operating Return on Assets (OROA)		 14.66% 14.71% 15.01% 15.97% 13.61% 13.37% 13.18% 14.93% 14.13% 10.89%
Return on Assets (ROA)		 10.08% 9.91% 9.85% 10.50% 8.63% 8.73% 8.43% 9.74% 9.09% 6.96%
Return on Common Equity (ROCE)		 34.39% 29.09% 34.50% 31.20% 27.57% 28.10% 31.49% 30.48% 29.07% 27.53%
Return on Equity Simple (ROE_SIMPLE)		 31.71% 0.00% 34.84% 43.43% 41.86% 0.00% 28.74% 28.54% 28.35% 0.00%
Net Operating Profit after Tax (NOPAT)		 1,233 1,087 1,108 1,113 955 1,001 1,020 1,101 1,022 853
NOPAT Margin		 31.65% 29.15% 29.90% 30.09% 26.74% 27.20% 27.72% 29.74% 28.25% 24.11%
Net Nonoperating Expense Percent (NNEP)		 0.95% 0.92% 0.92% 0.93% 0.88% 0.91% 0.89% 0.94% 0.85% 0.90%
Return On Investment Capital (ROIC_SIMPLE)		 - 8.72% - - - 3.28% - - - 2.75%
Cost of Revenue to Revenue		 33.40% -6.73% 12.03% 10.87% 33.71% 74.21% 11.11% 10.43% 32.41% -12.57%
SG&A Expenses to Revenue		 17.05% 60.35% 38.07% 38.90% 19.60% -20.33% 40.99% 39.58% 18.65% 66.91%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 26.06% 69.46% 48.46% 49.50% 30.71% -9.48% 52.11% 50.45% 30.17% 81.80%
Earnings before Interest and Taxes (EBIT)		 1,616 1,434 1,505 1,497 1,305 1,331 1,395 1,476 1,390 1,126
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,994 1,829 1,898 1,903 1,708 1,736 1,805 1,886 1,806 1,548
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 4.33 6.45 4.92 7.24 6.67 5.64 5.79 5.18 5.18 4.98
Price to Tangible Book Value (P/TBV)		 4.51 6.80 5.13 7.24 6.67 5.89 6.04 5.41 5.40 5.16
Price to Revenue (P/Rev)		 3.83 4.27 4.01 4.55 4.14 4.61 4.99 4.47 4.56 4.28
Price to Earnings (P/E)		 13.64 15.40 14.13 16.68 15.94 18.43 20.16 18.16 18.26 17.93
Dividend Yield		 1.51% 1.33% 1.39% 1.25% 1.42% 1.29% 1.22% 1.38% 1.36% 1.49%
Earnings Yield		 7.33% 6.49% 7.08% 6.00% 6.27% 5.43% 4.96% 5.51% 5.48% 5.58%
Enterprise Value to Invested Capital (EV/IC)		 2.63 2.30 2.83 2.54 2.17 3.08 3.22 2.92 2.98 2.81
Enterprise Value to Revenue (EV/Rev)		 4.75 4.13 4.94 4.49 4.05 5.61 5.99 5.48 5.54 5.31
Enterprise Value to EBITDA (EV/EBITDA)		 9.20 8.09 9.49 8.77 8.03 11.36 12.13 11.14 11.15 10.96
Enterprise Value to EBIT (EV/EBIT)		 11.44 10.09 11.78 11.01 10.24 14.60 15.67 14.40 14.39 14.33
Enterprise Value to NOPAT (EV/NOPAT)		 15.16 13.40 15.70 14.68 13.79 19.70 21.18 19.45 19.41 19.32
Enterprise Value to Operating Cash Flow (EV/OCF)		 12.48 11.11 13.43 12.12 11.04 14.92 16.27 15.28 15.11 14.72
Enterprise Value to Free Cash Flow (EV/FCFF)		 18.99 18.64 20.51 15.65 18.73 19.45 25.64 24.57 19.19 24.16
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 1.40 0.00 1.45 0.00 0.00 1.55 1.47 1.47 1.43 1.48
Long-Term Debt to Equity		 1.39 0.00 1.45 0.00 0.00 1.50 1.42 1.42 1.43 1.43
Financial Leverage		 0.98 1.01 1.03 1.10 1.18 1.18 1.15 1.19 1.22 1.21
Leverage Ratio		 3.16 2.99 3.21 3.02 3.21 3.24 3.38 3.17 3.23 3.47
Compound Leverage Factor		 2.78 2.57 2.78 2.62 2.71 2.75 2.87 2.72 2.75 2.83
Debt to Total Capital		 58.35% 0.00% 59.23% 0.00% 0.00% 60.73% 59.48% 59.46% 58.90% 59.67%
Short-Term Debt to Total Capital		 0.50% 0.00% 0.04% 0.00% 0.00% 1.83% 1.79% 1.79% 0.02% 1.95%
Long-Term Debt to Total Capital		 57.85% 0.00% 59.20% 0.00% 0.00% 58.90% 57.69% 57.67% 58.88% 57.71%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.03% 0.00% 0.03% 0.00% 0.00% 0.02% 0.02% 0.01% 0.02% 0.02%
Common Equity to Total Capital		 41.62% 78.75% 40.74% 78.18% 77.57% 39.26% 40.50% 40.53% 41.08% 40.32%
Debt to EBITDA		 2.41 0.00 2.27 0.00 0.00 2.56 2.56 2.57 2.54 2.63
Net Debt to EBITDA		 1.78 0.00 1.79 0.00 0.00 2.03 2.02 2.06 1.97 2.13
Long-Term Debt to EBITDA		 2.38 0.00 2.27 0.00 0.00 2.48 2.49 2.49 2.54 2.54
Debt to NOPAT		 3.96 0.00 3.76 0.00 0.00 4.44 4.47 4.49 4.42 4.63
Net Debt to NOPAT		 2.93 0.00 2.97 0.00 0.00 3.52 3.53 3.59 3.44 3.75
Long-Term Debt to NOPAT		 3.93 0.00 3.76 0.00 0.00 4.30 4.34 4.35 4.42 4.48
Altman Z-Score		 2.01 5.41 2.10 5.87 5.41 2.12 2.25 2.13 2.15 1.98
Noncontrolling Interest Sharing Ratio		 0.07% 10.24% 0.07% 10.49% 10.74% 10.86% 0.05% 10.68% 10.70% 0.04%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 1.72 0.83 1.45 0.51 0.63 1.04 1.15 1.16 1.39 0.86
Quick Ratio		 1.54 0.79 1.23 0.46 0.46 0.88 0.95 0.98 1.19 0.71
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 315 -201 -9.90 828 -184 1,055 300 242 1,070 53
Operating Cash Flow to CapEx		 285.60% 293.53% 287.59% 239.61% 276.65% 224.59% 206.87% 218.24% 272.82% 168.86%
Free Cash Flow to Firm to Interest Expense		 1.63 -1.01 -0.05 4.12 -0.91 5.17 1.43 1.16 5.20 0.26
Operating Cash Flow to Interest Expense		 8.94 6.39 6.22 6.08 7.65 7.30 5.16 5.21 8.18 6.71
Operating Cash Flow Less CapEx to Interest Expense		 5.81 4.21 4.06 3.54 4.88 4.05 2.67 2.82 5.18 2.73
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.35 0.38 0.37 0.39 0.37 0.37 0.35 0.37 0.37 0.34
Accounts Receivable Turnover		 10.42 0.00 11.41 0.00 0.00 0.00 10.54 0.00 0.00 10.70
Inventory Turnover		 7.93 0.00 5.47 0.00 4.55 0.00 4.01 0.00 3.91 3.57
Fixed Asset Turnover		 0.44 0.44 0.45 0.44 0.43 0.43 0.42 0.42 0.42 0.41
Accounts Payable Turnover		 2.50 0.00 1.81 0.00 0.00 0.00 1.35 0.00 0.00 1.21
Days Sales Outstanding (DSO)		 35.03 0.00 31.98 0.00 0.00 0.00 34.64 0.00 0.00 34.13
Days Inventory Outstanding (DIO)		 46.00 0.00 66.75 0.00 80.26 0.00 91.03 0.00 93.30 102.33
Days Payable Outstanding (DPO)		 146.28 0.00 201.85 0.00 0.00 0.00 270.30 0.00 0.00 302.81
Cash Conversion Cycle (CCC)		 -65.24 0.00 -103.13 0.00 80.26 0.00 -144.63 0.00 93.30 -166.35
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 26,245 26,739 26,474 26,572 27,384 26,685 27,194 27,431 27,336 27,485
Invested Capital Turnover		 0.56 0.57 0.58 0.57 0.55 0.55 0.55 0.54 0.54 0.54
Increase / (Decrease) in Invested Capital		 918 1,288 1,118 285 1,139 -54 720 859 -48 800
Enterprise Value (EV)		 69,054 61,415 74,839 67,421 59,492 82,292 87,588 80,207 81,350 77,213
Market Capitalization		 55,683 63,348 60,691 68,377 60,852 67,587 72,991 65,392 66,945 62,230
Book Value per Share		 $6.01 $4.67 $5.98 $4.64 $4.55 $6.06 $6.43 $6.45 $6.67 $6.48
Tangible Book Value per Share		 $5.76 $4.43 $5.73 $4.64 $4.55 $5.81 $6.17 $6.18 $6.39 $6.26
Total Capital		 30,933 12,469 30,256 12,074 11,756 30,518 31,103 31,128 31,477 31,010
Total Debt		 18,050 0.00 17,922 0.00 0.00 18,533 18,501 18,508 18,541 18,503
Total Long-Term Debt		 17,895 0.00 17,911 0.00 0.00 17,975 17,944 17,951 18,535 17,897
Net Debt		 13,362 -1,933 14,140 -956 -1,360 14,700 14,592 14,811 14,400 14,978
Capital Expenditures (CapEx)		 604 433 435 510 561 663 524 499 618 822
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -442 -2,355 -424 -1,967 -2,432 -742 -480 -244 -642 -855
Debt-free Net Working Capital (DFNWC)		 1,957 -422 1,045 -1,011 -1,072 694 1,005 998 1,014 150
Net Working Capital (NWC)		 1,802 -422 1,034 -1,011 -1,072 136 448 441 1,008 -456
Net Nonoperating Expense (NNE)		 122 121 121 129 127 132 127 138 128 133
Net Nonoperating Obligations (NNO)		 13,362 14,270 14,140 14,498 15,628 14,700 14,592 14,811 14,400 14,978
Total Depreciation and Amortization (D&A)		 378 395 393 406 403 405 410 410 416 422
Debt-free, Cash-free Net Working Capital to Revenue		 -3.04% -15.86% -2.80% -13.09% -16.54% -5.06% -3.28% -1.67% -4.37% -5.88%
Debt-free Net Working Capital to Revenue		 13.45% -2.84% 6.90% -6.73% -7.29% 4.73% 6.87% 6.82% 6.91% 1.03%
Net Working Capital to Revenue		 12.38% -2.84% 6.83% -6.73% -7.29% 0.93% 3.06% 3.01% 6.87% -3.14%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.52 $0.45 $0.48 $0.49 $0.42 $0.44 $0.46 $0.50 $0.46 $0.37
Adjusted Weighted Average Basic Shares Outstanding		 2.12B 2.14B 2.05B 2.02B 1.99B 2.01B 1.96B 1.94B 1.94B 1.94B
Adjusted Diluted Earnings per Share		 $0.52 $0.45 $0.48 $0.49 $0.42 $0.44 $0.46 $0.49 $0.46 $0.38
Adjusted Weighted Average Diluted Shares Outstanding		 2.13B 2.14B 2.06B 2.03B 2.00B 2.01B 1.96B 1.95B 1.94B 1.94B
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.45 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 2.10B 2.06B 2.03B 2.01B 1.98B 1.96B 1.95B 1.94B 1.93B 1.89B
Normalized Net Operating Profit after Tax (NOPAT)		 1,212 1,044 1,102 1,104 950 995 1,020 1,094 1,023 851
Normalized NOPAT Margin		 31.11% 28.00% 29.74% 29.84% 26.61% 27.03% 27.70% 29.57% 28.27% 24.04%
Pre Tax Income Margin		 36.53% 33.11% 35.19% 35.04% 30.85% 30.63% 32.19% 34.23% 32.72% 25.97%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 8.37 7.21 7.49 7.45 6.43 6.52 6.64 7.06 6.75 5.44
NOPAT to Interest Expense		 6.39 5.46 5.51 5.54 4.70 4.91 4.86 5.27 4.96 4.12
EBIT Less CapEx to Interest Expense		 5.24 5.03 5.32 4.91 3.67 3.27 4.15 4.67 3.75 1.47
NOPAT Less CapEx to Interest Expense		 3.26 3.29 3.35 3.00 1.94 1.66 2.36 2.88 1.96 0.15
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 20.85% 20.71% 20.03% 21.15% 22.87% 24.05% 24.61% 25.06% 24.99% 26.80%
Augmented Payout Ratio		 125.70% 135.71% 131.39% 122.27% 125.62% 118.97% 98.12% 90.67% 73.90% 91.27%

Frequently Asked Questions About CSX's Financials

When does CSX's fiscal year end?

According to the most recent income statement we have on file, CSX's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has CSX's net income changed over the last 9 years?

CSX's net income appears to be on an upward trend, with a most recent value of $3.47 billion in 2024, rising from $1.97 billion in 2015. The previous period was $3.67 billion in 2023.

What is CSX's operating income?
CSX's total operating income in 2024 was $5.25 billion, based on the following breakdown:
  • Total Gross Profit: $13.02 billion
  • Total Operating Expenses: $7.77 billion
How has CSX revenue changed over the last 9 years?

Over the last 9 years, CSX's total revenue changed from $11.81 billion in 2015 to $14.54 billion in 2024, a change of 23.1%.

How much debt does CSX have?

CSX's total liabilities were at $30.26 billion at the end of 2024, a 0.1% increase from 2023, and a 31.1% increase since 2015.

How much cash does CSX have?

In the past 9 years, CSX's cash and equivalents has ranged from $401 million in 2017 to $3.13 billion in 2020, and is currently $933 million as of their latest financial filing in 2024.

How has CSX's book value per share changed over the last 9 years?

Over the last 9 years, CSX's book value per share changed from 11.95 in 2015 to 6.48 in 2024, a change of -45.8%.

Remove Ads

Related Companies

This page (NASDAQ:CSX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
DOGE tax surprise
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...
Altimetry | Sponsored
Amazon Shocker
Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...
Stansberry Research | Sponsored
Caught on Camera: Elon Musk’s “Area 51”
You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...
Brownstone Research | Sponsored
Three new patents reveal Elon and Trump’s secret “Project America”
Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...
Timothy Sykes | Sponsored